Medicare drug wars

The proposed federal policy rule that would make major changes to Medicare Advantage and the Medicare Part D drug program is being blasted by both health insurers and pharmacy benefit managers. One of the most controversial suggestions would mandate a certain amount of drug company rebates be applied to what people pay at the point of sale at pharmacies. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.